The H25 antibody is a murine-derived monoclonal antibody generated against the HSE-2 cell line. It specifically recognizes human NK cells and subsets of peripheral mononuclear cells with cytotoxic activity . This antibody is critical for studying innate immune responses, cancer immunology, and viral infection mechanisms.
NK Cell Identification: H25 binds to medium-sized lymphocytes with granular cytoplasm, most of which express Fc receptors for IgG .
Cytotoxic Activity: Targets cells involved in natural killer and antibody-dependent cellular cytotoxicity (ADCC) .
Tissue Distribution: Reacts with 10% of E rosette-forming T cells, subsets of monocytes, and thymocytes but not platelets or red blood cells .
H25 has been utilized in multiple experimental contexts:
Immunohistochemistry (IHC): Detects NK cells in tissue sections .
Immunoprecipitation (IP): Isolates surface antigens for functional studies .
Flow Cytometry: Identifies NK cell populations in peripheral blood .
In a study screening bone marrow metastases in prostate cancer patients, monoclonal antibodies like H25 helped detect occult tumor cells via immuno-histochemical assays .
H25’s reactivity with conserved epitopes on cytotoxic cells supports its use in tracking immune responses in cancer and infections .
H25 is often compared to H366, another monoclonal antibody with overlapping reactivity:
| Feature | H25 | H366 |
|---|---|---|
| Target Cells | NK cells, T-cell lines, monocytes | Similar to H25 |
| Molecular Weight | 96 kDa + 53 kDa | Not specified |
| Diagnostic Use | IHC, IP, flow cytometry | Research applications only |
Both antibodies define similar cell subsets but differ in binding affinities for specific epitopes .
Cancer Research: H25 aids in identifying metastatic cells in bone marrow aspirates, improving sensitivity over traditional histopathology .
Infection Studies: Its role in NK cell activity analysis informs antiviral and antitumor immunity mechanisms .
PCMP-H25 Antibody appears to be related to the PCMP (Pentatricopeptide repeat-containing) protein family found in Arabidopsis thaliana, similar to other PCMP antibodies available for research (PCMP-E23, PCMP-E10, PCMP-H18, PCMP-H12, etc.) . Based on the pattern of related antibodies, it likely targets a specific PCMP protein expressed in this model plant organism. PCMP proteins generally function in RNA processing within plant organelles, particularly in mitochondria and chloroplasts.
Researchers should note that when working with plant-specific antibodies like those targeting PCMP proteins, validation in the specific experimental system is crucial, as the antibody's performance can vary significantly depending on plant tissue type and experimental conditions.
While specific information for PCMP-H25 is limited, established protocols for similar plant-specific antibodies suggest optimal storage "in the dark at 2-4°C for working solutions, or below -30°C for long-term storage" . Antibodies targeting plant proteins are typically shipped in small volumes (0.1ml/2ml) with preservatives like 0.1% sodium azide .
For maximum stability:
Store in small aliquots to minimize freeze-thaw cycles
Keep in temperature-stable conditions
Protect from light exposure
Centrifuge briefly before opening
Follow manufacturer guidelines for reconstitution if lyophilized
Based on typical applications of similar antibodies targeting plant proteins, PCMP-H25 Antibody would likely be validated for:
Western blotting/immunoblotting
Immunohistochemistry (IHC)
Enzyme-linked immunosorbent assay (ELISA)
Immunoprecipitation (IP)
Chromatin immunoprecipitation (ChIP) if the target has DNA-binding properties
When planning experiments, researchers should first validate the antibody for their specific application through appropriate controls, including tissue from knockout mutants if available.
Rigorous validation of antibody specificity is critical for reliable research outcomes. Drawing from established protocols used with other antibodies, a comprehensive validation approach includes:
Positive and negative controls:
Recombinant protein expressing the target as a positive control
Knockout/knockdown plant tissue as a negative control
Comparison with known expression patterns from literature
Cross-reactivity testing:
Test against related PCMP proteins
Perform peptide competition assays where the antibody is pre-incubated with immunizing peptide
Quantitative specificity assessment:
A properly validated antibody should show strong reactivity with its target and minimal cross-reactivity with other proteins, as demonstrated in specificity testing of other research antibodies .
Based on methodologies successfully employed with other plant protein antibodies:
Sample preparation:
Extract proteins using buffer containing protease inhibitors
Determine protein concentration (Bradford or BCA assay)
Prepare samples in Laemmli buffer with reducing agent
Gel electrophoresis and transfer:
Antibody incubation:
Detection:
This protocol is adapted from successful Western blotting methods using specific antibodies in plant research contexts, with timing and buffer compositions that have proven effective .
Plant tissues present unique challenges for immunohistochemistry due to cell walls and autofluorescence. An optimized protocol would include:
Tissue fixation and processing:
Fix tissues in 4% paraformaldehyde
Perform gradual dehydration and paraffin embedding
Cut sections at 5-10 μm thickness
Antigen retrieval and blocking:
Antibody incubation:
Apply primary antibody at optimized dilution
Incubate at 4°C overnight for best results
Wash thoroughly with TBST
Apply fluorophore-conjugated secondary antibody
When capturing images, consistent microscope settings should be maintained across all samples to allow for quantitative comparisons, similar to the standardized approach used in other antibody validation studies .
High background is a frequent challenge when working with plant tissues due to their complex matrix. Based on troubleshooting approaches in antibody research:
Sources of high background:
Insufficient blocking
Plant-specific compounds (phenolics, secondary metabolites)
Non-specific antibody binding
Excessive antibody concentration
Solutions:
Additional plant-specific considerations:
Include polyvinylpyrrolidone (PVP) in extraction buffer to remove phenolics
Add reducing agents to prevent non-specific disulfide bonding
Consider specialized plant protein extraction kits
These approaches have successfully reduced background in other plant antibody applications and would likely improve results with PCMP-H25 Antibody.
Distinguishing specific from non-specific signals requires careful experimental design:
Essential controls:
Recombinant protein as positive control
Knockout/knockdown plant tissue as negative control
Secondary antibody-only control to identify non-specific binding
Peptide competition assay to confirm epitope specificity
Analytical approaches:
Quantitative assessment table:
| Sample Type | Expected Signal | Potential Interpretation |
|---|---|---|
| Wild-type tissue | Strong, specific band at target MW | True positive |
| Knockout tissue | No band at target MW | Confirms specificity |
| Recombinant protein | Single band at expected MW | Positive control |
| With competing peptide | Significantly reduced signal | Confirms epitope specificity |
| Secondary antibody only | No bands | Confirms primary antibody specificity |
This analytical framework has proven valuable in distinguishing genuine signals from artifacts in other antibody validation studies .
Quantitative analysis of protein expression requires rigorous methodology:
Western blot quantification:
Include standard curve of recombinant protein
Ensure detection is in linear range
Use image analysis software for densitometry
Normalize to consistent loading controls
Comparative tissue analysis:
Data analysis and presentation:
This methodological approach ensures scientifically rigorous quantification of protein expression levels across different tissue types, similar to established protocols for other plant protein antibodies.
Co-immunoprecipitation (Co-IP) is a powerful approach for studying protein interactions:
Experimental design:
Extract proteins under non-denaturing conditions
Pre-clear lysate with Protein A/G beads
Immunoprecipitate with PCMP-H25 Antibody
Identify interacting partners by Western blot or mass spectrometry
Critical controls:
IgG-only control precipitation
Lysate from knockout plants as negative control
Input sample (pre-immunoprecipitation)
Reverse Co-IP to confirm interactions
Advanced variations:
Crosslinking prior to extraction to capture transient interactions
Stimulus-dependent Co-IP to detect conditional interactions
Tandem affinity purification for enhanced specificity
This methodology has been successfully applied with other plant protein antibodies to characterize protein interaction networks.
Plant proteins undergo various post-translational modifications (PTMs) that affect antibody recognition:
Identifying potential PTMs:
Multiple bands may indicate phosphorylation, glycosylation, or other modifications
Higher molecular weight bands could represent ubiquitination or SUMOylation
Lower molecular weight bands might be proteolytic fragments
Validation approaches:
Treat samples with phosphatases to confirm phosphorylation
Use PTM-specific antibodies in parallel experiments
Compare with predicted molecular weights
Analyze samples by mass spectrometry
Experimental conditions affecting PTM detection:
Buffer composition (phosphatase inhibitors)
Sample preparation temperature
Tissue type and developmental stage
Stress conditions or treatments
Understanding how PTMs affect antibody recognition is critical for accurate data interpretation, as demonstrated in studies with other plant protein antibodies .
Integrating antibody-based detection with genetic approaches provides comprehensive insights:
| Approach | Methodology | Strengths | Complementarity with Antibody Detection |
|---|---|---|---|
| T-DNA insertional mutants | Genotype plants with insertions in target gene | Complete loss of gene function | Provides negative control tissue for antibody validation |
| RNAi knockdown | Generate plants with reduced target expression | Tunable expression reduction | Creates dosage series for quantitative antibody validation |
| CRISPR-Cas9 editing | Create precise mutations in target gene | Specific modification of protein domains | Tests antibody epitope specificity |
| Overexpression lines | Express tagged versions of target protein | Increases detection sensitivity | Confirms antibody recognizes intended target |
This integrated approach has been successfully employed in studies with other plant proteins, allowing researchers to correlate protein levels with phenotypic observations and functional outcomes.
Novel antibody technologies offer exciting possibilities for plant research:
Single-domain antibodies (nanobodies):
Smaller size allows better penetration of plant cell walls
Greater stability under varying conditions
Potential for in vivo imaging applications
Recombinant antibody fragments:
Custom-designed for specific epitopes
Reduced cross-reactivity
Potential for multiplexed detection
Proximity labeling combined with antibody detection:
Identifies protein neighborhoods in plant organelles
Maps spatiotemporal interactions
Reveals transient binding partners
These emerging technologies could overcome current limitations in plant protein research, similar to advances demonstrated in other fields of antibody-based research .
Current challenges and potential solutions include:
Signal amplification methods:
Tyramide signal amplification (TSA)
Polymer-based detection systems
Rolling circle amplification
Sample enrichment strategies:
Subcellular fractionation
Affinity purification
Protein concentration techniques
Advanced imaging approaches:
Super-resolution microscopy
Single-molecule detection
Correlative light and electron microscopy
Multi-antibody cocktail approaches:
These methodological advances could significantly improve the detection sensitivity for low-abundance plant proteins, overcoming current technical limitations.
Bioinformatics approaches can significantly enhance antibody-based research:
Epitope prediction:
In silico analysis of potential cross-reactivity
Structural modeling of antibody-antigen interactions
Prediction of accessibility in native protein conformation
Network analysis:
Integration of Co-IP data with known interaction networks
Pathway enrichment analysis of identified interactors
Functional clustering of co-regulated proteins
Multi-omics integration:
Correlation of protein levels with transcriptomic data
Metabolic pathway mapping based on protein function
Systems biology modeling of regulatory networks
These computational approaches have been successfully applied in other antibody-based research fields and could significantly enhance the interpretation of experimental data obtained with PCMP-H25 Antibody.